Company news
Zhejiang Medicine Co., Ltd. news in 2026
Zhejiang Medicine Co., Ltd.'s news releases, calls and decks from 2026, newest first.
(600216)"Zhejiang Medicine Co., Ltd."Announcement on Progress in Repurchasing Shares
November 3, 2026
(600216)"Zhejiang Medicine Co., Ltd."Report for Q3 2026
October 27, 2026
(600216)"Zhejiang Medicine Co., Ltd."Announcement on Progress in Repurchasing Shares
October 15, 2026
(600216)"Zhejiang Medicine Co., Ltd."Announcement on Progress in Repurchasing Shares
October 9, 2026
Announcement on Convening the 2026 Semi-annual Performance Briefing
September 7, 2026
Announcement on Progress in Repurchasing Shares
September 1, 2026
Announcement on Resolutions of the 14th Meeting of the 10th Board of Directors
August 25, 2026
Announcement on Initial Repurchase of Shares through Call Auction
August 24, 2026
Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders of Unrestricted Shares Concerning Share Repurchase
July 17, 2026
Announcement on Resolutions of the 13th Meeting of the 10th Board of Directors
July 14, 2026
Announcement on Expiration of the Share Reduction Plan of a Shareholder Holding More Than 5% of the Company's Shares and No Share Reduction
July 7, 2026
Announcement on Implementation of Dividend Distribution for 2025
July 2, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
June 11, 2026
Announcement on Convening Performance Briefing for 2025 and Q1 2026
June 8, 2026
Announcement on Progress in Cooperation in Investment with a Private Fund
May 27, 2026
Announcement on Cooperative Investment with Private Fund
May 15, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
April 27, 2026
Announcement on the Self-Inspection Report on the Trading of Stocks by Insiders of Inside Information Related to the Spin-off of Affiliated Subsidiaries
April 24, 2026
Announcement on Resolutions of the 12th Meeting of the 10th Board of Directors
April 23, 2026
Announcement on 2025 Annual Profit Distribution Plan
April 10, 2026
Announcement on Plan of Shareholding Reduction through Call Auction by Shareholder with Over 5% Shares
March 16, 2026
Announcement on Initiation of Phase II Clinical Trial of ARX305
March 5, 2026
Announcement on C-Round Capital Increase of Subsidiary Novocodex Biopharmaceuticals with the Introduction of Strategic Investors and Waiver of Preemptive Subscription Rights
March 3, 2026
Announcement on No Shareholding Reduction upon Expiration of Shareholding Reduction Plan by Shareholder with Over 5% Shares
January 22, 2026
Announcement on the Results of Grants for the 2025 Restricted Stock Incentive Plan
January 6, 2026